Please login to the form below

Not currently logged in
Email:
Password:

Titan Pharmaceuticals

This page shows the latest Titan Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan Pharma and Braeburn Pharma's Probuphine.

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    An FDA panel has backed approval of a long-acting buprenorphine implant for the management of opioid addiction developed by Titan Pharma and partner Braeburn Pharma. ... Titan and Braeburn attempted to secure US approval for their product in 2013 but

  • US launch for Novartis' Fanapt

    Fanapt was originally developed by Titan Pharmaceuticals, but then under the license agreement from Novartis, Vanda Pharmaceuticals undertook to pursue the drug's phase III development programme and complete product registration. ... America, CEO,

  • Lack of treatments depress EU bladder cancer market

    Fenretinide. Vitamin A analogue. NCI. III. Gallium maltolate. Gallium (semi-metalic). Titan Pharmaceuticals. ... DUSA Pharmaceuticals. II. MCC (urocidin). Mycobacterial cell wall-DNA complex. Bioniche Life Sciences.

More from news
Approximately 3 fully matching, plus 1 partially matching documents found.

Latest appointments

  • New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals

    Cagnoni, chief executive officer of Rubius. Titan Pharmaceuticals. Kate DeVarney has joined Titan Pharmaceuticals’ board of directors, where she currently serves as executive vice president and chief scientific officer. ... DeVarney joined Titan over

  • Ex-Bayer R&D chief joins Gemmus Pharma board

    Rubin is currently executive chairman of Titan Pharmaceuticals and previously served as head of global research and development for Bayer Schering Pharma. ... His past positions include chairman of Schering Berlin and president of Schering AG's Berlex

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Origins Insights

Origins are part of the Resonant Group. Using novel research methodologies, we dig deeper to deliver authentic audience experiences that...

Latest intelligence

Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...